NIV was feasible and associated with successful outcomes in a majority of patients with AECOPD and moderate to severe neurological impairment. Specific parameters, including initial GCS, blood pressure, SpO2, and blood gas profiles, can help predict outcomes and treatment efficacy.
Fabbri et al. (Thu,) studied this question.